New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.
Sydney Crago
Advertisement
Sydney Crago is managing editor of the Eyecare Network at MJH Life Sciences.
Articles by Sydney Crago
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Addressing Complex Dermatologic Conditions in Children | Fall Clinical Derm 2025
2
Zoryve Cream Improves Sleep in Atopic Dermatitis Patients | Fall Clinical Derm 2025
3
New Therapies Targeting OX40 Pathway Offer Hope for Atopic Dermatitis | Fall Clinical Derm 2025
4
When It Comes to Interleukins and Atopic Dermatitis,13 Is a Lucky Number |Fall Clinical Derm 2025
5
